Characteristic | No. of cancers observed | No. of cancers expected | Standardized incidence ratio (95% CI) |
---|---|---|---|
All cancers | 895 | 905.38 | 0.99 (0.93–1.06) |
Head and neck | 69 | 71.91 | 0.96 (0.75–1.21) |
Digestive | 326 | 360.33 | 0.90 0.81–1.01) |
Esophagus | 11 | 18.03 | 0.61 (0.30–1.09) |
Stomach | 47 | 49.88 | 0.94 (0.69–1.25) |
Colon and rectum | 136 | 138.40 | 0.98 (0.82–1.16) |
Liver and biliary tract | 117 | 136.91 | 0.85 (0.71–1.02) |
Pancreas | 15 | 17.10 | 0.88 0.49–1.45) |
Lung and mediastinum | 130 | 119.05 | 1.09 (0.91–1.30) |
Bone and soft tissue | 14 | 6.88 | 2.03 (1.11–3.41) |
Skin | 20 | 18.57 | 1.08 (0.66–1.66) |
Breast | 68 | 83.24 | 0.82 (0.63–1.04) |
Genitourinary | 171 | 156.01 | 1.10 (0.94–1.27) |
Cervix | 18 | 26.96 | 0.67 (0.40–1.06) |
Uterus | 15 | 12.35 | 1.22 (0.68–2.00) |
Ovary | 8 | 11.01 | 0.73 (0.31–1.43) |
Prostate | 63 | 48.78 | 1.29 (0.99–1.65) |
Bladder | 40 | 32.51 | 1.23 (0.88–1.68) |
Kidney | 27 | 24.41 | 1.11 (0.73–1.61) |
Thyroid | 17 | 15.25 | 1.12 (0.65–1.79) |
Hematologic | 45 | 38.70 | 1.16 (0.85–1.56) |
Non-Hodgkin lymphoma | 25 | 19.56 | 1.28 (0.83–1.89) |
Hodgkin disease | 1 | 0.76 | 1.31 (0.03–7.31) |
Multiple myeloma | 11 | 5.42 | 2.03 (1.01–3.63) |
Leukemia | 8 | 12.96 | 0.62 (0.27–1.22) |
Others | 35 | 35.45 | 0.99 (0.69–1.37) |
Note: CI = confidence interval.